TAS-115 mesylate
Cat. No.:YN440209
产品名称: | TAS-115 mesylate |
CAS No.: | 1688673-09-7 |
Chemical Name: | 4-[2-fluoro-4-[[[(2-phenylacetyl)amino]thioxomethyl]amino]phenoxy]-7-methoxy-N-methyl-6-quinolinecarboxamide, monomethanesulfonate |
Synonyms: | TAS-115 methanesulfonate |
分子量: | 614.66 |
分子式: | C₂₈H₂₇FN₄O₇S₂ |
SMILES: | CS(=O)(O)=O.O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC(CC4=CC=CC=C4)=O)=S)C=C3F)C2=C1)NC |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | TAS-115 mesylate是一种有效的VEGFR和肝细胞生长因子受体 (c-Met/HGFR) 的靶向激酶抑制剂,能够抑制 rVEGFR2 和 rMET 的活性,IC50值分别为 30 和 32 nM。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Fujita, H., Miyadera, K., Kato, M., et al.The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profileMol. Cancer Ther.12(12),2685-2696(2013)
Koyama, K., Goto, H., Morizumi, S., et al.The tyrosine kinase inhibitor TAS-115 attenuates bleomycin-induced lung fibrosis in miceAm. J. Respir. Cell Mol. Biol.60(4),478-487(2019)